Generali Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Generali Asset Management's BMY Position: Q3 2026 in Review
Generali Asset Management increased its Bristol-Myers Squibb (BMY) stake by 4.2% in Q3 2026, buying an estimated $673K and bringing the position to 265,264 shares worth $16.6M. The position accounts for 0.29% of the portfolio, ranked #75.
Generali Asset Management first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Generali Asset Management held 265,264 shares of Bristol-Myers Squibb worth $16.6M as of Q3 2026.
- Generali Asset Management bought 10,647 Bristol-Myers Squibb shares in Q3 2026, an estimated $673K.
- Bristol-Myers Squibb made up 0.29% of Generali Asset Management's portfolio in Q3 2026, its #75 holding.
- Generali Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
- 907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.